Stay updated on LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.

Latest updates to the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the former operating-status notice about government funding and the previous Revision: v3.4.1.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, with guidance to check cc.nih.gov and opm.gov. The page revision tag changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a 'Show glossary' option and updates footer metadata, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing 'No FEAR Act data' and the older 'Last Update Submitted that met QC Criteria' reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThis update shows a minor revision update: Revision: v3.3.4 replacing v3.3.3, with no changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now includes a consolidated Locations section listing study sites by state (Alabama, California, Maryland, Massachusetts, Michigan, New York, North Carolina, Ohio, Pennsylvania) and updates the revision to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.9%

- Check92 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.0%

Stay in the know with updates to LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.